1. Home
  2. QNCX vs AZI Comparison

QNCX vs AZI Comparison

Compare QNCX & AZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • AZI
  • Stock Information
  • Founded
  • QNCX 2012
  • AZI 2010
  • Country
  • QNCX United States
  • AZI China
  • Employees
  • QNCX N/A
  • AZI N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • AZI
  • Sector
  • QNCX Health Care
  • AZI
  • Exchange
  • QNCX Nasdaq
  • AZI Nasdaq
  • Market Cap
  • QNCX 47.7M
  • AZI 129.3M
  • IPO Year
  • QNCX 2019
  • AZI 2024
  • Fundamental
  • Price
  • QNCX $1.53
  • AZI $0.21
  • Analyst Decision
  • QNCX Strong Buy
  • AZI
  • Analyst Count
  • QNCX 5
  • AZI 0
  • Target Price
  • QNCX $8.00
  • AZI N/A
  • AVG Volume (30 Days)
  • QNCX 336.8K
  • AZI 739.1K
  • Earning Date
  • QNCX 08-12-2025
  • AZI 01-27-2025
  • Dividend Yield
  • QNCX N/A
  • AZI N/A
  • EPS Growth
  • QNCX N/A
  • AZI N/A
  • EPS
  • QNCX N/A
  • AZI N/A
  • Revenue
  • QNCX N/A
  • AZI $124,737,000.00
  • Revenue This Year
  • QNCX N/A
  • AZI N/A
  • Revenue Next Year
  • QNCX N/A
  • AZI N/A
  • P/E Ratio
  • QNCX N/A
  • AZI N/A
  • Revenue Growth
  • QNCX N/A
  • AZI 9.86
  • 52 Week Low
  • QNCX $0.51
  • AZI $0.19
  • 52 Week High
  • QNCX $2.45
  • AZI $4.05
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 66.23
  • AZI N/A
  • Support Level
  • QNCX $1.43
  • AZI N/A
  • Resistance Level
  • QNCX $1.68
  • AZI N/A
  • Average True Range (ATR)
  • QNCX 0.13
  • AZI 0.00
  • MACD
  • QNCX 0.03
  • AZI 0.00
  • Stochastic Oscillator
  • QNCX 83.02
  • AZI 0.00

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares

Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.

Share on Social Networks: